Celldex Therapeutics, Inc.

NASDAQ:CLDX

Biotechnology

Healthcare
$27.96 +0.47%

+$0.16 today

Market cap
$2.20B
Beta
0.93
P/E (TTM)
-7.8
EPS (TTM)
-$4.26
52W Low $19.52High $35.79

Volume 0.75M

Average 0.94M

Balance Sheet

Inspect the capital base behind the business.

Assets

$582.98M

FY 2025 · Annual

-26.4% YoY

Liabilities

$55.82M

FY 2025 · Annual

+23.1% YoY

Equity

$527.16M

FY 2025 · Annual

-29.4% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents39.14M29.43M34.81M28.36M28.87M
Short-term Investments369.11M275.52M386.88M696.93M489.7M
Net Receivables172K347K4.53M700K2.02M
Inventory00000
Other Current Assets005.47M21.18M14.08M
Total Current Assets410.84M317.69M431.69M747.16M534.66M
Property, Plant & Equipment (Net)6.52M7.75M6.64M8.24M7.77M
Goodwill00000
Intangible Assets27.19M27.19M27.19M27.19M27.19M
Long-term Investments00000
Tax Assets00000
Other Non-current Assets104K104K107K9.75M13.36M
Total Non-current Assets33.82M35.04M33.93M45.18M48.32M
Total Assets444.65M352.74M465.63M792.34M582.98M
Account Payables1.23M3.34M3.49M3.27M1.18M
Short-term Debt00000
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities1.55M990K3.99M942K1.23M
Total Current Liabilities16.53M18.61M31.13M39.5M50.99M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities7.35M5.33M4.4M3.47M4.04M
Total Non-current Liabilities8.65M7.92M5.33M5.83M4.83M
Total Liabilities25.18M26.53M36.46M45.34M55.82M
Common Stock47K47K56K66K67K
Retained Earnings(1.14B)(1.26B)(1.4B)(1.56B)(1.81B)
Accumulated OCI1.89M1.26M3.31M3.31M3.63M
Other Stockholders Equity00000
Minority Interest00000
Total Equity419.48M326.2M429.17M747.01M527.17M
Total Debt3.04M4.03M2.54M3.81M2.34M
Net Debt(36.1M)(25.4M)(32.27M)(24.54M)(26.54M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$27.0M
Short-term Investments$623.4M
Receivables$355.0K
Other Current$13.1M
Total Current Assets$663.7M
PP&E (Net)$20.9M
Intangible Assets$27.2M
Other Non-current$9.7M
Total Non-current Assets$57.8M
Total Assets$721.5M

Analysis

Selected assets total $721.5M for Latest. The largest visible component is Short-term Investments at $623.4M, about 86.4% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
S-3ASRS-3ASR filingNov 5, 2026
10-QQuarterly reportNov 5, 2026
8-KCurrent reportNov 5, 2026
SC 13G/ASC 13G/A filingOct 7, 2026
8-KCurrent reportSep 22, 2026

How much cash does CLDX have?

Celldex Therapeutics, Inc. (CLDX) reported $28.87M in cash and equivalents in fiscal 2025.

How much debt does CLDX carry?

Celldex Therapeutics, Inc. (CLDX) reported $2.34M of total debt, with net debt of -$26.54M.